drug spending

Five Facts About U.S. Drug Spending
Five Facts About U.S. Drug SpendingWhat you need to know about prescription drugs in America.
Prescription Drug Spending Slowing
Prescription Drug Spending SlowingNew QuintilesIMS data shows that the growth in drug spending is leveling off.
CVS: Generics and Biosimilars Are Key to Its Drug Spending DeclineDrug spending is going down at CVS Caremark. Here’s why.
Drug Spending Slows for Major Pharmacy Benefit Managers
New 340B drug rule sets drugmaker finesConsumer health groups are praising Health and Human Services’ (HHS) new rule on the Medicaid 340B drug discount program, which sets a ceiling on drug prices.
US drug spending predicted to drop
US drug spending predicted to dropThe US growth rate for spending on medicines is expected to fall in 2016 and beyond, according to new research.
Four ways Medicare Part D has affected costs for diabetic patientsUnderstand Medicare Part D’s design and its coverage gap to offer the most affordable prescription drug options for patients.
Cheaper generic EpiPen doesn't quiet criticsDespite offering a generic version of its EpiPen, Mylan has been unable to curb the backlash that began in late August over the cost of its epinephrine injection.
EpiPen discounts offered after pricing flapAfter protests by patients, parents and Congressional representatives, Mylan said it would offer discounts on its epinephrine EpiPen Auto-Injector treatment to stop allergic reactions.
Are PCSK9 inhibitors too pricey?
Are PCSK9 inhibitors too pricey?PCSK9 inhibitors such as alirocumab (Praluent, Sanofi) and evolocumab (Repatha, Amgen) are priced too high to benefit the US healthcare system, according to a new study.